drug
tolododekin alfa
Phase 1updated 3mo agoby Ankyra Therapeutics Inc
Phase 1community read0 votes
indications
indications
NSCLCBreast CancerMelanoma
all catalysts(0)
nothing on the calendar yet
Trials studying tolododekin alfa
- phase1Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors
- phase1A Study of Tolododekin Alfa (ANK-101) in Combination With an Anti-PD-1/PD-L1 Antibody in Participants With Advanced Non-Small Cell Lung Cancer
- phase1A Study of Tolododekin Alfa (ANK-101) in Renal Allograft Recipients With High Risk Cutaneous Squamous Cell Carcinoma
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that